NIH-funded research R01 grant

IGF factors and binding proteins in gestational diabetes and fetal growth

Official title: Impact of insulin-like growth factors and binding proteins on gestational diabetes and fetal growth

Funded at Harvard Pilgrim Health Care, INC. · NIH-11295705 · Data updated 2026-11-12

This research looks at how placental IGF binding proteins may influence gestational diabetes and fetal growth, aiming to understand why some pregnancies are more risk-prone.

More Diabetes research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionHarvard Pilgrim Health Care, INC.
NIH-funded
Lab location1 site (Canton, UNITED STATES)
Project startSeptember 17, 2018
Project endJune 30, 2031
Funding year2026
Award (this year)$661,312
NIH project number2R01HD094150-06A1
Project IDNIH-11295705 on NIH RePORTER

Who could benefit from this research

Could help

Pregnant individuals at risk for gestational diabetes or with suspected placental IGF pathway involvement.

Less likely to help

Pregnant individuals without IGF pathway involvement or those not eligible for the specific study methods may not benefit directly.

What this research studies

Pregnant people could benefit from clearer understanding of how insulin-like growth factors affect glucose control and fetal growth. The project builds on prior findings to test whether IGFBP1 and IGF2 in the placenta drive insulin resistance during pregnancy. Researchers will use human samples and animal models to explore causal roles and identify potential targets for precise therapies. The work seeks to translate lab findings into better management of gestational diabetes and healthier fetal development.

Why it matters

Potential benefit: If successful, this work could lead to targeted therapies or better risk stratification for gestational diabetes and fetal growth issues.

How similar studies have gone: Prior research suggests IGF axis plays a role in pregnancy metabolism, but causal links in humans are not yet established, making this approach promising but exploratory.

Where this research is happening

  • Harvard Pilgrim Health Care, INC.
    Canton, United States
    Active

Researchers

  • Principal investigator: Hivert, Marie-France — Harvard Pilgrim Health Care, INC.
  • Study coordinator: Hivert, Marie-France

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.